文献速递血液透析通路

麻醉方式及其他变量与头静脉型动静脉瘘1年功能通畅性的关联

Association of anesthetic modality and other variables on 1-year functional patency of cephalic-based arteriovenous fistulae.
PubMed 文献 · J Vasc Surg · 2024-04-03

该回顾性研究纳入2014至2019年间五家安全网医院的818例头静脉型血液透析动静脉瘘患者,评估麻醉方式对12个月功能通畅性的影响。结果显示区域、局部与全身麻醉组间12个月功能通畅性无统计学显著差异(P=0.343),而既往动静脉瘘/人工血管史、术中全身抗凝和静脉直径与12个月功能通畅性独立相关。

要点

  • 818例头静脉型动静脉瘘12个月总体功能通畅率为78.7%。
  • 上臂动静脉瘘12个月通畅率81.3%高于腕部73.3%(P=0.009)。
  • 区域、局部与全身麻醉组间12个月功能通畅性无统计学显著差异(P=0.343)。

核心结论

  • 麻醉方式与头静脉型动静脉瘘12个月功能通畅性无关联。
  • 需进一步研究以明确哪些患者可能从区域麻醉中获益。

研究设计与样本

  • 回顾性研究,纳入2014至2019年间五家安全网医院连续接受头静脉型血液透析通路的患者,共818例头静脉型动静脉瘘。
  • 主要终点为12个月功能通畅性,并分别分析前臂下段/腕部与上臂动静脉瘘。
  • 采用双变量及多变量逻辑回归模型评估麻醉方式与12个月瘘功能的关系。

主要发现

  • 12个月总体功能通畅率为78.7%,其中上臂动静脉瘘为81.3%,腕部动静脉瘘为73.3%(P=0.009)。
  • 比较区域、局部和全身麻醉,12个月功能通畅与不通畅患者间麻醉方式无统计学显著差异(P=0.343)。
  • 多变量回归分析显示,既往动静脉瘘/人工血管史(OR 0.24;P=0.007)、术中全身抗凝(OR 2.49;P<0.001)和静脉直径(OR 1.85;P=0.039)与12个月动静脉瘘功能通畅性独立相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究以明确哪些患者可能从区域麻醉中获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Some studies suggest that regional anesthesia provides better patency for arteriovenous fistula (AVF) for hemodialysis access as compared to local and general anesthesia. This study evaluates the impact of anesthetic modality on long term fistula function at 12 months. METHODS: A retrospective review of patients undergoing cephalic vein-based hemodialysis access in consecutive cases between 2014 and 2019 was conducted from five safety net hospitals. The primary endpoint was functional patency at 12 months. Subset analysis individually evaluated cephalic-based lower forearm and wrist vs upper arm AVFs. Bivariate and multivariate logistic regression models evaluated the relationship between anesthetic modality and fistula function at 12 months. RESULTS: There were 818 cephalic-based fistulas created during the study period. The overall 12-month functional patency rate was 78.7%, including an 81.3% patency for upper arm AVF and 73.3% for wrist AVF (P = .009). There was no statistically significant difference among patients with functional and nonfunctional AVFs at 12 months with respect to anesthetic modality when comparing regional, local, and general anesthesia (P = .343). Multivariate regression analysis identified that history of AVF/arteriovenous graft (odds ratio [OR], 0.24; P = .007), receiving intraoperative systemic anticoagulation (OR, 2.49; P < .001), and vein diameter (OR, 1.85; P = .039) as independently associated with AVF functional patency at 12 months. CONCLUSIONS: There was no association between anesthetic modality and functional patency of cephalic-based AVFs at 12 months. Further studies are needed to better define which patients may benefit from regional anesthesia.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ugarte R, de Virgilio C, Valadez M, et al. Association of anesthetic modality and other variables on 1-year functional patency of cephalic-based arteriovenous fistulae. J Vasc Surg. 2024. PMID: 38574954. doi:10.1016/j.jvs.2024.03.442

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。